Anavex Life Sciences Corp (AVXL)

[Hoskuld]

None of that makes any sense, BAR123. CM converts all his options to shares except those shares he needs to liquidate to cover transaction costs. Insider buys are NBD. And CM isn't going anywhere: 11 years of planning play out this year.

Short covering will happen when it happens. Generally that happens when material events make shorting unattractive. That is what we are all waiting for. Last year we sat around $4-$5 per share this year we sit at $8-$9 per share because MAA was filed and peer review was published and OLE results are good.

Buyback is not going to happen. The company sells shares regularly to keep capital on hand high enough to give them flexibility. They are not going to rebuy what they are selling

This is pre-revenue biotech: share are massively f***ed with until the game suddenly ends. That will happen soon.